Par Committee seeks creation of separate drug controller for AYUSH medicines

Image
Press Trust of India New Delhi
Last Updated : Apr 05 2018 | 7:20 PM IST

A parliamentary committee today sought creation of a separate drug controller for AYUSH medicines and drugs in a time-bound manner to ensure they are on a par with international standards.

The committee, which pointed out that market of Indian herbal drugs was declining worldwide, lamented the delay by the AYUSH ministry in fulfilling the assurance given on the issues of separate drug controller and legislations for education and practice of AYUSH systems of medicine.

According to the report submitted in the Lok Sabha today, the ministry had moved a proposal for setting up a separate drug controller for AYUSH medicines and it was put up for Cabinet approval.

However, upon a directive from PMO, the ministry decided to set up a vertical structure of AYUSH in the existing Central Drugs Standard Control Organization (CDSCO).

"Putting AYUSH drugs under the same structure of CDSCO as allopathic medicines is gross injustice towards AYUSH medicines and will not lead to fulfilment of the assurance which was give," the report stated.

Since an inordinate length of time has been taken by the ministry without fulfilling the assurance, the committee directed the ministry to fulfil it in a time-bound manner and, meanwhile, also furnish a part implementation report detailing steps taken by it to ensure quality, safety, efficacy and standard of AYUSH drugs in the country.

The committee pointed out that two more assurances pertaining to the legislation for education and practice of AYUSH systems of medicine have been kept pending by the ministry for more than two years.

The committee expressed concern to note that there is no licensing authority for AYUSH medicines despite the fact that these are eternal medicinal practices.

It observed that absence of licensing authority for AYUSH medicines is the main reason for these medicines not getting the recognition they deserve in the country and abroad.

It also pointed out that there are no specific pharmacists for selling AYUSH medicines and no course has been prescribed for them as a result of which many countries have banned AYUSH medicines in their markets.

The committee also asked the Ministry of AYSUH to streamline the mechanism for implementation of eight assurances given by the government which are still pending.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 05 2018 | 7:20 PM IST

Next Story